Applied Clinical Trials podcast

ACT Brief: Community Research Financing Gaps, Neuroscience Endpoint Data, and Teva’s Biosimilar Deal

0:00
1:57
Retroceder 15 segundos
Avanzar 15 segundos
In today’s ACT Brief, we examine why community research needs lasting financing and infrastructure, how electronic outcome tools can strengthen neuroscience endpoints, and how Teva is licensing two biosimilars from Samsung Bioepis.

Otros episodios de "Applied Clinical Trials"